Park Won Sun, Kang Sung Hyun, Son Youn Kyoung, Kim Nari, Ko Jae-Hong, Kim Hyoung Kyu, Ko Eun A, Kim Chi Dae, Han Jin
National Research Laboratory for Mitochondrial Signaling, FIRST Mitochondrial Research Group, Department of Physiology and Biophysics, College of Medicine, Biohealth Products Research Center, Cardiovascular and Metabolic Disease Center, Inje University, 633-165 Gaegeum-Dong, Busanjin-Gu, Busan 613-735, Republic of Korea.
Department of Pharmacology, College of Medicine and Medical Research Center for Ischemic Tissue Regeneration, Pusan National University, Busan, Republic of Korea.
Biochem Biophys Res Commun. 2007 Oct 12;362(1):31-36. doi: 10.1016/j.bbrc.2007.07.057. Epub 2007 Jul 23.
We examined the effects of the mitochondrial Ca(2+)-activated K(+) (mitoBK(Ca)) channel activator NS 1619 on L-type Ca(2+) channels in rat ventricular myocytes. NS 1619 inhibited the Ca(2+) current in a dose-dependent manner. NS 1619 shifted the activation curve to more positive potentials, but did not have a significant effect on the inactivation curve. Pretreatment with inhibitors of membrane BK(Ca) channel, mitoBK(Ca) channel, protein kinase C, protein kinase A, and protein kinase G had little effect on the Ca(2+) current and did not alter the inhibitory effect of NS 1619 significantly. The application of additional NS 1619 in the presence of isoproterenol, a selective beta-adrenoreceptor agonist, reduced the Ca(2+) current to approximately the same level as a single application of NS 1619. In conclusion, our results suggest that NS 1619 inhibits the Ca(2+) current independent of the mitoBK(Ca) channel and protein kinases. Since NS 1619 is widely used to study mitoBK(Ca) channel function, it is essential to verify these unexpected effects of NS 1619 before experimental data can be interpreted accurately.
我们研究了线粒体钙激活钾(mitoBK(Ca))通道激活剂NS 1619对大鼠心室肌细胞L型钙通道的影响。NS 1619以剂量依赖的方式抑制钙电流。NS 1619使激活曲线向更正的电位移动,但对失活曲线没有显著影响。用膜BK(Ca)通道、mitoBK(Ca)通道、蛋白激酶C、蛋白激酶A和蛋白激酶G的抑制剂预处理对钙电流影响很小,且未显著改变NS 1619的抑制作用。在选择性β肾上腺素能受体激动剂异丙肾上腺素存在的情况下,额外应用NS 1619可将钙电流降低至与单次应用NS 1619大致相同的水平。总之,我们的结果表明,NS 1619抑制钙电流,且不依赖于mitoBK(Ca)通道和蛋白激酶。由于NS 1619被广泛用于研究mitoBK(Ca)通道功能,因此在准确解释实验数据之前,必须验证NS 1619的这些意外效应。